Conduit Pharmaceuticals Inc. (CDT) — Cash Flow Reinvestment Rate
Latest as of June 2026:
0.95x
Conduit Pharmaceuticals Inc. (CDT) has a Cash Flow Reinvestment Rate of 0.95x as of June 2026, reinvesting $40.66 Million (capex $40.66 Million ) from operating cash flow of $42.74 Million. See CDT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.95x
(Capex + Investments) / Operating CF
Total Reinvested
$40.66 Million
Capex + Investments
Operating Cash Flow
$42.74 Million
USD
Capital Expenditures
$40.66 Million
USD
Annual Cash Flow Reinvestment Rate for Conduit Pharmaceuticals Inc. (None–None)
Year-by-year capital reinvestment analysis for Conduit Pharmaceuticals Inc.. See CDT financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow